Allegion (ALLE)
(Delayed Data from NYSE)
$142.71 USD
+1.78 (1.26%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $142.71 0.00 (0.00%) 4:42 PM ET
2-Buy of 5 2
B Value C Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$142.71 USD
+1.78 (1.26%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $142.71 0.00 (0.00%) 4:42 PM ET
2-Buy of 5 2
B Value C Growth D Momentum C VGM
Zacks News
What's in the Offing for Allegion (ALLE) This Earnings Season?
by Zacks Equity Research
Weakness in the Allegion Americas segment and increasing costs are to dent Allegion's (ALLE) first-quarter 2024 results.
Honeywell (HON) to Report Q1 Earnings: Is a Beat in Store?
by Zacks Equity Research
Honeywell's (HON) first-quarter results are likely to have benefited from strength across most of its businesses. Weakness in the warehouse automation market might have been a spoilsport.
Is a Beat in Store for A. O. Smith (AOS) in Q1 Earnings?
by Zacks Equity Research
Improving water heater volumes in North America, enhanced supply chains and higher shipments are likely to aid A. O. Smith's (AOS) Q1 2024 results.
Will Increasing Expenses Dent IDEX's (IEX) Q1 Earnings?
by Zacks Equity Research
Weakness in the HST segment, the escalating cost of sales, rising selling, general and administrative expenses and forex woes are likely to hurt IDEX's (IEX) first-quarter performance.
Danaher (DHR) Gears Up to Post Q1 Earnings: Is a Beat Likely?
by Zacks Equity Research
Danaher's (DHR) Q1 earnings are likely to be hurt by weakness in the Biotechnology unit. Improving supply chains and strong price realization are expected to be positives.
Allegion (ALLE) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Allegion (ALLE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Allegion (ALLE) Gains 28% in a Year: Will the Trend Last?
by Zacks Equity Research
Strength in the Allegion Americas segment and accretive acquisitions bode well for Allegion (ALLE). The company's measures to reward its shareholders are encouraging.
What's in the Offing for Alcoa (AA) This Earnings Season?
by Zacks Equity Research
Alcoa's (AA) first-quarter 2024 results are expected to bear the brunt of decreasing value-add product sales due to overall lower market demand. However, lower raw material and production costs are expected to provide some relief.
What's in Store for Lakeland (LAKE) This Earnings Season?
by Zacks Equity Research
Lower sales of disposable and chemical product lines and increasing raw material costs are likely to hurt Lakeland's (LAKE) fourth-quarter fiscal 2024 performance.
Will Allegion (ALLE) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Allegion (ALLE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Is Axon (AXON) Up 2.1% Since Last Earnings Report?
by Zacks Equity Research
Axon (AXON) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Allegion (ALLE): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
Allegion (ALLE) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Why Is Allegion (ALLE) Up 3.2% Since Last Earnings Report?
by Zacks Equity Research
Allegion (ALLE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Hold Allegion (ALLE) in Your Portfolio
by Zacks Equity Research
Allegion (ALLE) benefits from strength in its non-residential business, acquired businesses and shareholder-friendly policies. However, softness in its residential products unit is concerning.
Allegion (ALLE) Buys Dorcas, Strengthens Product Offerings
by Zacks Equity Research
Allegion's (ELA) acquisition of Dorcas will enable it to strengthen its product offerings and boost its international segment.
BRC or ALLE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BRC vs. ALLE: Which Stock Is the Better Value Option?
Allegion (ALLE) Q4 Earnings Top Estimates, Revenues Up Y/Y
by Zacks Equity Research
Allegion's (ALLE) fourth-quarter 2023 organic sales increase 2.6% due to solid growth in the company's non-residential business.
Allegion (ALLE) Surpasses Q4 Earnings Estimates
by Zacks Equity Research
Allegion (ALLE) delivered earnings and revenue surprises of 7.01% and 1.67%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for Allegion (ALLE) This Earnings Season?
by Zacks Equity Research
Strength in the Allegion Americas segment and accretive acquisition are likely to aid Allegion's (ALLE) fourth-quarter 2023 results.
BRC or ALLE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BRC vs. ALLE: Which Stock Is the Better Value Option?
Napco (NSSC) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Napco (NSSC) delivered earnings and revenue surprises of 30.77% and 7.95%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Hold on to Allegion (ALLE) Stock Now
by Zacks Equity Research
Allegion (ALLE) is set to gain from strength in the Allegion International segment and accretive acquisitions. The company's measures to reward its shareholders are encouraging.
BRC vs. ALLE: Which Stock Is the Better Value Option?
by Zacks Equity Research
BRC vs. ALLE: Which Stock Is the Better Value Option?
BRC or ALLE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BRC vs. ALLE: Which Stock Is the Better Value Option?
Allegion (ALLE) Gains From Business Strength Amid Headwinds
by Zacks Equity Research
Allegion (ALLE) is likely to benefit from strength across its businesses, strong prolonged actions and acquired businesses. However, lower demand for residential products remains a concern.